|
Spire Healthcare Group PLC on Thursday announced its revenue grew in 2025, offsetting ‘significant cost headwinds’ amid an ongoing strategic review. The London-based healthcare provider, reported £1.58 billion in revenue in 2025, up 4.5% from £1.51 billion in the previous financial year. However, a backdrop of ‘increased costs and changes in the NHS commissioning environment towards the end of the year’ coupled with £27.9 million in adjustments born out of the strategic review, took pretax profit down 51.4% year-on-year to £18.6 million from £38.3 million 12 months prior. Shareholders return also narrowed, with the board recommending a dividend of 1.5 pence a share, down 34.8% from 2.3 pence a share in 2024. Chief Executive Officer Justin Ash said that the year was one of ‘significant transformation’ amid a cost control and efficiency drive which ‘reshaped the organisation to be more agile and responsive’, creating ‘a strong platform for improving patient experience and future growth’. Savings strategies will continue in 2026, with the plan ‘ahead of our previously communicated guidance of circa £30 million’. While the healthcare provider expects growing revenue from private patients, NHS volumes, which represent 30% of hospital revenue, will be ‘a material uncertainty across the sector as a result of Integrated Care Board budgetary restrictions and a resultant slowdown in commissioning activity with the independent sector’, the company said in its outlook for the first quarter. For the next financial year as a whole, Spire targets earnings before interest, tax, depreciation, and amortisation ‘broadly in line’ with 2025’s £268.6 million on an adjusted basis, up 3.4% from £260.0 million in 2024, as long as NHS volumes remain within the planned scenario. The strategic review has seen two companies potentially interested in making an takeover offer for Spire Healthcare, Bridgepoint Advisers Ltd and Triton Investment Advisers LLP. The deadline for any bid to be made was recently extended to March 21. Spire Healthcare shares were down 2.2% to 190.60 pence each on Thursday afternoon in London. Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
